http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005033278-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7449ca99fbf1c556219fe28876cbf2a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_31fb964e2148aff14f5bfc5f5ae6fbaf
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70514
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-09
filingDate 2004-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c59026cf99d3327e81f62cc758026c7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce096d3b03c3edd23e8dff332e7c9d3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a6047e54c04db86279121d8f2a1d2f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d526537ae3fc13bf3a823decafc2b00b
publicationDate 2005-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005033278-A2
titleOfInvention In vivo efficacy of ny-eso-1 plus iscom
abstract The present invention is based on the discovery that the administration of the protein NY-ESO-1, together with an adjuvant based on saponin makes it possible to obtain an unexpectedly strong immune response against cells expressing NY-ESO-1. Preferably, the combination is administered intramuscularly.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8173141-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111135310-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111135310-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1684800-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1684800-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7776343-B1
priorityDate 2003-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5287620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87858538
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247001123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226416392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57472993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649

Total number of triples: 47.